Oncometabolites in pancreatic cancer: Strategies and its implications.
1/5 보강
Pancreatic cancer (PanCa) is a catastrophic disease, being third lethal in both the genders around the globe.
APA
Maiti A, Mondal S, et al. (2024). Oncometabolites in pancreatic cancer: Strategies and its implications.. World journal of experimental medicine, 14(4), 96005. https://doi.org/10.5493/wjem.v14.i4.96005
MLA
Maiti A, et al.. "Oncometabolites in pancreatic cancer: Strategies and its implications.." World journal of experimental medicine, vol. 14, no. 4, 2024, pp. 96005.
PMID
39713078 ↗
Abstract 한글 요약
Pancreatic cancer (PanCa) is a catastrophic disease, being third lethal in both the genders around the globe. The possible reasons are extreme disease invasiveness, highly fibrotic and desmoplastic stroma, dearth of confirmatory diagnostic approaches and resistance to chemotherapeutics. This inimitable tumor microenvironment (TME) or desmoplasia with excessive extracellular matrix accumulation, create an extremely hypovascular, hypoxic and nutrient-deficient zone inside the tumor. To survive, grow and proliferate in such tough TME, pancreatic tumor and stromal cells transform their metabolism. Transformed glucose, glutamine, fat, nucleotide metabolism and inter-metabolite communication between tumor and TME in synergism, impart therapy resistance, and immunosuppression in PanCa. Thus, a finer knowledge of altered metabolism would uncover its metabolic susceptibilities. These unique metabolic targets may help to device novel diagnostic/prognostic markers and therapeutic strategies for better management of PanCa. In this review, we sum up reshaped metabolic pathways in PanCa to formulate detection and remedial strategies of this devastating disease.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Crosstalk Between -Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma.
- The tumor microenvironment shapes gastric cancer progression by coordinating immune suppression and metabolic reprogramming.
- Deubiquitination-driven adaptive programs in hepatocellular carcinoma: The emerging role of USP22 in hypoxia, metabolic rewiring, and drug resistance.
- Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy.
- GlycoRNA in cancer immune regulation and progression: biological mechanisms and translational therapeutic prospects.
- Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches.